Christopher Lemieux

8PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Visual culturesCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 24, 2026
Cell Therapy Transplant Canada (CTTC) Consensus-Based Review for the Use of Supportive Care and Topical Therapies for Chronic Graft-Versus-Host Disease.

|Aug 26, 2026
Canadian Hematology Consensus Group Recommendations for the Management of Relapsed and/or Refractory Follicular Lymphoma.

|Feb 26, 2026
Real-World Outcomes of Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Large B-Cell Lymphoma in Canada.

Christopher Lemieux, John Kuruvilla, Mona Shafey

|Jan 27, 2026
Abstracts of the Cell Therapy Transplant Canada 2024 Annual Conference.

Stephanie A Maier, Frédéric Barabé, Tobias Berg

|Oct 28, 2025
Contemporary Fixed-Duration Treatment Options in the First-Line Setting of Chronic Lymphocytic Leukemia: Perspectives from a Publicly Funded Healthcare System.

Christopher Lemieux, Chai W Phua, K Sue Robinson

|Oct 24, 2025
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival.

Sergio Rodriguez-Rodriguez, Nihar Desai, Christopher Lemieux

Pageof 2

Frequent Collaborators

3 joint publications

Mohamed Elemary

2 joint publications

Kylie Lepic

2 joint publications

David Allan

2 joint publications

Sylvie Lachance